Immune checkpoint inhibitors: risk of severe cardiovascular events

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2018年 / 1729卷 / 1期
关键词：
D O I：
10.1007/s40278-018-54637-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [1] Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
    Torrente, Maria
    Blanco, Mariola
    Franco, Fabio
    Garitaonaindia, Yago
    Calvo, Virginia
    Collazo-Lorduy, Ana
    Gutierrez, Lourdes
    Cristobal Sanchez, Juan
    Gonzalez-del-Alba, Aranzazu
    Hernandez, Roberto
    Mendez, Miriam
    Cantos, Blanca
    Nunez, Beatriz
    Sousa, Pedro A. C.
    Provencio, Mariano
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [2] Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
    Luo, Lingli
    Liu, Yuxin
    Lu, Jingfen
    Zhang, Yifei
    Fan, Gang
    Tang, Xiaojun
    Guo, Weiming
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations
    Chiang, Cho-Han
    Chiang, Cho-Hung
    Ma, Kevin Sheng-Kai
    Hsia, Yuan Ping
    Lee, Yu-wen
    Wu, Han-Ru
    Chiang, Cho-Hsien
    Peng, Chun-Yu
    Wei, James Cheng-Chung
    Shiah, Her-Shyong
    Peng, Cheng-Ming
    Neilan, Tomas G.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (12) : 1389 - 1398
  • [4] Cardiovascular events after the initiation of immune checkpoint inhibitors
    Suzuki, Yuta
    Kaneko, Hidehiro
    Tamura, Yuichi
    Okada, Akira
    Fujiu, Katsuhito
    Michihata, Nobuaki
    Takeda, Norifumi
    Jo, Taisuke
    Morita, Hiroyuki
    Node, Koichi
    Yasunaga, Hideo
    Komuro, Issei
    HELIYON, 2023, 9 (05)
  • [5] Incidence of cardiovascular events in patients treated with immune checkpoint inhibitors
    Laenens, D.
    Yu, Y.
    Santens, B.
    Jacobs, J.
    Beuselinck, B.
    Bechter, O.
    Wauters, E.
    Staessen, J.
    Janssens, S.
    Van Aelst, L.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2565 - 2565
  • [6] Retrospective Analysis of Cardiovascular Events With the Use of Immune Checkpoint Inhibitors
    Tarun, Tushar
    Bostick, Brian P.
    Baswaraj, Deepa
    Basra, Nishchayjit
    Khan, Meeshal
    Bickel, Trent
    CIRCULATION, 2020, 142
  • [7] Incidence of Cardiovascular Events in Patients Treated With Immune Checkpoint Inhibitors
    Laenens, Dorien
    Yu, Yuling
    Santens, Beatrice
    Jacobs, Johanna
    Beuselinck, Benoit
    Bechter, Oliver
    Wauters, Els
    Staessen, Jan
    Janssens, Stefan
    Van Aelst, Lucas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (29) : 3430 - +
  • [8] Immune checkpoint inhibitors increase risk of cardiac events
    Reactions Weekly, 2021, 1837 (1) : 11 - 11
  • [9] Immune checkpoint inhibitors: Unravelling atherosclerotic cardiovascular risk
    Gray, Rhys
    Manisty, Charlotte
    Cheng, Richard
    Dastidar, Amardeep
    Mamas, Mamas
    Ghosh, Arjun
    ATHEROSCLEROSIS, 2025, 403
  • [10] Immune checkpoint inhibitors associated cardiovascular immune-related adverse events
    Jo, Wonyoung
    Won, Taejoon
    Daoud, Abdel
    Cihakova, Daniela
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345